Striking At The Heart Of Hepatitis B Virus - A New Drug May Wipe-Out Infection In More Patients

NewYork-Presbyterian/Weill Cornell clinician-scientists are studying how a new drug might be used to treat chronic hepatitis B infection (HBV). Clevudine is a compound that may provide a longer lasting viral suppression after treatment is stopped, compared to drugs currently prescribed to treat HBV. This new compound is being studied in subjects with chronic HBV who have never been treated before by one of the current standard medications for HBV.

More: continued here

Filed under: Liver Disease / Hepatitis on July 16th, 2008